Evidence map›Paper›PMID 18085422›Full record

ArticleTransgenic research2008

Integration site analysis in transgenic mice by thermal asymmetric interlaced (TAIL)-PCR: segregating multiple-integrant founder lines and determining zygosity.

Manoj M Pillai, Gopalakrishnan M Venkataraman, Steven Kosak, Beverly Torok-Storb

Abstract read
PubMed Publisher
In one paragraph

Article in Transgenic research, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.8field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 37 citations in OpenAlex.

  1. Article
  2. Transgene Mapping in Animals: What to Choose?International journal of molecular sciences · 2025
    Review
  3. Comparative analysis of two independent Myh6-Cre transgenic mouse lines.Journal of molecular and cellular cardiology plus · 2024
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Manoj M PillaiClinical Research Division, Fred Hutchinson Cancer Research Center, 1100 Fairview Avenue N., Seattle, WA 98109-1024, USA.
Gopalakrishnan M Venkataraman
Steven Kosak
Beverly Torok-Storb
Fred Hutch Cancer Center · US

Funding

Translational Bioimaging Core Shared ResourceP30CA015704 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI Marian Esvelt · 1985 to 2026
$296.4M
REGULATION OF HEMATOPOIESISR01HL062923 · NHLBI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI TOROK-STORB, BEVERLY J. · 1998 to 2008
$3.0M
Monocyte derived CXCL7 in the marrow microenvironmentK08DK073701 · NIDDK · UNIVERSITY OF COLORADO DENVER · PI PILLAI, MANOJ M. · 2006 to 2010
$641k
Role of macrophages in MSC-mediated recovery of hematopoiesis after irradiationR03DK082757 · NIDDK · UNIVERSITY OF COLORADO DENVER · PI PILLAI, MANOJ M. · 2009 to 2010
$137k
NCI NIH HHS P30 CA 015704NHLBI NIH HHS R01 HL 062923NIDDK NIH HHS K08 DK073701NIDDK NIH HHS K08 DK 073707NIDDK NIH HHS R03 DK082757
6 · The paper itself

Abstract

When transgenic mice are created by microinjection of DNA into the pronucleus, the sites of DNA integration into the mouse genome cannot be predicted. Most methods based on polymerase chain reaction (PCR) that have been used for determining the integration site of foreign DNA into a genome require specific reagents and/or complicated manipulations making routine use tedious. In this report we demonstrate the use of a PCR-based method-TAIL-PCR (Thermal Asymmetric Interlaced PCR) which relies on a series of PCR amplifications with gene specific and degenerate primers to reliably amplify the integration sites. By way of example, using this approach, three separate integration sites were found (on chromosomes 8, 15 and 17) in one transgenic founder. As the sites on chromosomes 8 and 15 failed to segregate in any subsequent progeny, whole chromosome paints were done to determine if translocations involving chromosomes 8 and 15 occurred at the time of transgene integration. Whole chromosome painting could not detect translocations, suggesting that the rearrangements likely involve only small stretches of chromosomes. Site-specific primers were used to identify the progeny carrying only one integration site; these mice were then used as sub-founders for subsequent breedings. Integration site specific primers were used to distinguish homozygous progeny from heterozygotes. TAIL-PCR thus provides an easy and reliable way to (1) identify multiple integration sites in transgenic founders, (2) select breeders with one integration site, and (3) determine zygosity in subsequent progeny. Use of this strategy may also be considered to map integration sites in situations of unexpected phenotype or embryonic lethality while creating new transgenic mice.

Indexed as

Genetic Carrier ScreeningHomozygoteAnimalsAntigens, CDAntigens, Differentiation, MyelomonocyticBlotting, SouthernBreedingCD68 MoleculeChromosomes, MammalianFemaleFounder EffectMaleMiceMice, TransgenicPolymerase Chain ReactionPromoter Regions, GeneticAntigens, CDAntigens, Differentiation, MyelomonocyticCD68 MoleculeCD68 protein, mouse

Identifiers

PMID18085422
OpenAlexW2071991588

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.